Royalty Pharma (RPRX) News Today $31.91 +0.22 (+0.71%) As of 10:24 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Royalty Pharma plc (NASDAQ:RPRX) Given Average Rating of "Buy" by AnalystsShares of Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) have been given a consensus recommendation of "Buy" by the five brokerages that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation, three have issued a buy recommApril 24 at 4:34 AM | marketbeat.comRoyalty Pharma plc Announces Second Quarter 2025 Dividend Payment of $0.22 per Class A Ordinary ShareApril 23 at 3:29 PM | nasdaq.comRoyalty Pharma (NasdaqGS:RPRX) Declares US$0.22 Dividend for Q2 2025April 23 at 3:29 PM | finance.yahoo.comCerity Partners LLC Reduces Position in Royalty Pharma plc (NASDAQ:RPRX)Cerity Partners LLC decreased its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 47.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 17,359 shares of the biopharmaceutical company's stock after selling 15,537 shares duringApril 23 at 3:32 AM | marketbeat.comCanada Pension Plan Investment Board Grows Holdings in Royalty Pharma plc (NASDAQ:RPRX)Canada Pension Plan Investment Board grew its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 5.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 805,615 shares of the biopharmaceutical company's stockApril 22 at 4:52 AM | marketbeat.comGuggenheim Capital LLC Cuts Holdings in Royalty Pharma plc (NASDAQ:RPRX)Guggenheim Capital LLC trimmed its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 53.1% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 73,081 shares of the biopharmaceutical company's stock after selling 82,768 shares during thApril 22 at 4:06 AM | marketbeat.comRaymond James Financial Inc. Invests $19.99 Million in Royalty Pharma plc (NASDAQ:RPRX)Raymond James Financial Inc. bought a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 783,633 shares of the biopharmaceutical company's stock, vApril 22 at 3:49 AM | marketbeat.comBank of America Securities Reaffirms Their Buy Rating on Royalty Pharma (RPRX)April 22 at 2:45 AM | markets.businessinsider.comRoyalty Pharma price target raised to $42 from $41 at BofAApril 22 at 2:45 AM | markets.businessinsider.comRoyalty Pharma Declares Second Quarter 2025 DividendApril 21 at 4:15 PM | globenewswire.comJump Financial LLC Acquires Shares of 81,855 Royalty Pharma plc (NASDAQ:RPRX)Jump Financial LLC bought a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 81,855 shares of the biopharmaceutical company's stocApril 21 at 5:00 AM | marketbeat.comBridgewater Associates LP Purchases Shares of 49,416 Royalty Pharma plc (NASDAQ:RPRX)Bridgewater Associates LP acquired a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 49,416 shares of the biopharmaceutical company's stockApril 21 at 5:00 AM | marketbeat.comInvesco Ltd. Has $24.44 Million Stock Position in Royalty Pharma plc (NASDAQ:RPRX)Invesco Ltd. raised its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 33.2% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 957,893 shares of the biopharmaceutical company's stock after purchasing an additional 238,508 shares duringApril 21 at 4:03 AM | marketbeat.comSynovus Financial Corp Has $483,000 Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Synovus Financial Corp trimmed its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 81.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 18,919 shares of the biopharmaceutical company's stock after sApril 20, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by Evergreen Capital Management LLCEvergreen Capital Management LLC reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 58.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 107,657 shares of the biopharmaceuApril 19, 2025 | marketbeat.comRegal Investment Advisors LLC Decreases Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Regal Investment Advisors LLC cut its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 38.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 17,715 shares of the biopharmaceutical company's stock after sellinApril 19, 2025 | marketbeat.comOntario Teachers Pension Plan Board Sells 10,748 Shares of Royalty Pharma plc (NASDAQ:RPRX)Ontario Teachers Pension Plan Board lowered its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 32.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 22,601 shares of the biApril 19, 2025 | marketbeat.comSterling Capital Management LLC Boosts Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Sterling Capital Management LLC boosted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 30.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,595 shares of the biopharmaceutApril 19, 2025 | marketbeat.comTreasurer of the State of North Carolina Has $4.39 Million Position in Royalty Pharma plc (NASDAQ:RPRX)Treasurer of the State of North Carolina lessened its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 5.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 172,089 shares of the biophApril 18, 2025 | marketbeat.comBank of Montreal Can Sells 301,464 Shares of Royalty Pharma plc (NASDAQ:RPRX)Bank of Montreal Can cut its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 67.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 144,473 shares of the biopharmacApril 18, 2025 | marketbeat.comRoyalty Pharma to Announce First Quarter 2025 Financial Results on May 8, 2025April 17, 2025 | globenewswire.comPortolan Capital Management LLC Purchases 173,721 Shares of Royalty Pharma plc (NASDAQ:RPRX)Portolan Capital Management LLC boosted its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 101.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 344,185 shares of the biopharmaceuticaApril 16, 2025 | marketbeat.comLegal & General Group Plc Decreases Stake in Royalty Pharma plc (NASDAQ:RPRX)Legal & General Group Plc trimmed its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 15.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,633,882 shares of the biopharmaceutical company's stock after selling 478,679 shApril 14, 2025 | marketbeat.comRoyalty Pharma modifies acquisition agreementApril 13, 2025 | uk.investing.comAPG Asset Management N.V. Grows Stake in Royalty Pharma plc (NASDAQ:RPRX)APG Asset Management N.V. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 4.8% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 382,906 shares of the biopharmaceutical company's stock after purchasing an additional 17,4April 13, 2025 | marketbeat.comCenterBook Partners LP Sells 113,525 Shares of Royalty Pharma plc (NASDAQ:RPRX)CenterBook Partners LP trimmed its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 52.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 104,735 shares of the biopharmaceutical company's stock after selling 113,525 shares duriApril 12, 2025 | marketbeat.comAPG Asset Management US Inc. Takes $201,000 Position in Royalty Pharma plc (NASDAQ:RPRX)APG Asset Management US Inc. acquired a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 7,872 shares of the biopharmaceutical compaApril 12, 2025 | marketbeat.comAviva PLC Has $5.84 Million Position in Royalty Pharma plc (NASDAQ:RPRX)Aviva PLC raised its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 1,522.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 229,069 shares of the biopharmaceutical company's stock after buying an additional 214,April 12, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by Fmr LLCFmr LLC reduced its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 5.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 26,379,333 shares of the biopharmaceutical company's stock after selApril 11, 2025 | marketbeat.comADAR1 Capital Management LLC Trims Position in Royalty Pharma plc (NASDAQ:RPRX)ADAR1 Capital Management LLC lowered its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 95.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 49,963 shares of the biopharmaceutical company's stock after sApril 9, 2025 | marketbeat.comRussell Investments Group Ltd. Purchases 449,551 Shares of Royalty Pharma plc (NASDAQ:RPRX)Russell Investments Group Ltd. increased its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 32.0% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,855,791 shares of the biopharmApril 9, 2025 | marketbeat.comFranklin Resources Inc. Reduces Position in Royalty Pharma plc (NASDAQ:RPRX)Franklin Resources Inc. decreased its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 63.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 539,481 shares of the biopharmaceutical company's stock after selling 921,034 shares dApril 9, 2025 | marketbeat.comJPMorgan Chase & Co. Increases Stake in Royalty Pharma plc (NASDAQ:RPRX)JPMorgan Chase & Co. boosted its position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 8.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,395,242 shares of the biopharmaceuticApril 9, 2025 | marketbeat.comRoyalty Pharma appoints Biohaven CEO Vlad Coric to boardApril 8, 2025 | markets.businessinsider.comRoyalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of DirectorsApril 8, 2025 | markets.businessinsider.comRoyalty Pharma Appoints Vlad Coric, M.D. to the Company's Board of DirectorsApril 8, 2025 | globenewswire.comPrudential PLC Has $3.05 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Prudential PLC increased its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 220.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 119,443 shares of the biopharmaceutical company's stockApril 8, 2025 | marketbeat.comExodusPoint Capital Management LP Purchases New Shares in Royalty Pharma plc (NASDAQ:RPRX)ExodusPoint Capital Management LP purchased a new position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 143,601 shares of theApril 8, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by Headlands Technologies LLCHeadlands Technologies LLC decreased its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 88.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 4,489 shares of the biopharmaceutical cApril 8, 2025 | marketbeat.comGeode Capital Management LLC Acquires 46,765 Shares of Royalty Pharma plc (NASDAQ:RPRX)Geode Capital Management LLC grew its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 0.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,312,551 shares of the biopharmaceutical company's stock afterApril 8, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by Alliancebernstein L.P.Alliancebernstein L.P. cut its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 9.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,154,178 shares of the biopharmaceutical company's stock after selling 125,842 shares during the period.April 8, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by Rhenman & Partners Asset Management ABRhenman & Partners Asset Management AB lessened its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 3.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 595,000 shares of the biopharmaceutical compaApril 7, 2025 | marketbeat.comIntegrated Quantitative Investments LLC Makes New $390,000 Investment in Royalty Pharma plc (NASDAQ:RPRX)Integrated Quantitative Investments LLC bought a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 15,300 shares of the biopharmaceutical company's stock, valued at approximaApril 7, 2025 | marketbeat.comSchroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)Schroder Investment Management Group cut its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 64.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 196,359 shares of the biopharmaceutical company's stock aApril 7, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Lowers Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)Arrowstreet Capital Limited Partnership lowered its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 51.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 669,881 shares of the biopharmaceutical company's stock afteApril 6, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Bought by Sei Investments Co.Sei Investments Co. increased its holdings in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 58.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 109,557 shares of the biopharmaceutical company's stock after acquirinApril 6, 2025 | marketbeat.comCalifornia Public Employees Retirement System Sells 22,198 Shares of Royalty Pharma plc (NASDAQ:RPRX)California Public Employees Retirement System decreased its position in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 1.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,781,024 shares of the biopharmaceutical company's stockApril 4, 2025 | marketbeat.comAllstate Corp Makes New $299,000 Investment in Royalty Pharma plc (NASDAQ:RPRX)Allstate Corp bought a new stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 11,718 shares of the biopharmaceutical company's stock, valuedApril 4, 2025 | marketbeat.comPictet Asset Management Holding SA Trims Stake in Royalty Pharma plc (NASDAQ:RPRX)Pictet Asset Management Holding SA decreased its stake in shares of Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 4.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 326,372 shares of the biopharmaceutical company's stock after sApril 4, 2025 | marketbeat.comTrexquant Investment LP Raises Position in Royalty Pharma plc (NASDAQ:RPRX)Trexquant Investment LP lifted its stake in Royalty Pharma plc (NASDAQ:RPRX - Free Report) by 482.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 520,043 shares of the biopharmaceutical company's stock aApril 3, 2025 | marketbeat.com Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address RPRX Media Mentions By Week RPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RPRX News Sentiment▼1.240.94▲Average Finance News Sentiment RPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RPRX Articles This Week▼228▲RPRX Articles Average Week Get Royalty Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Zoetis News Today Corcept Therapeutics News Today Jazz Pharmaceuticals News Today Perrigo News Today Supernus Pharmaceuticals News Today Pacira BioSciences News Today Omeros News Today Nektar Therapeutics News Today Assembly Biosciences News Today Cumberland Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RPRX) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredThe Exact July Date the AI Correction Will End?AI stocks have cooled off—but Jeff Brown, the tech expert who picked Nvidia before it soared 222x, says one da...Brownstone Research | SponsoredThis Is The Moment You Betray Trump (Or Prove Them Wrong)They said you wouldn’t last—that Bidenflation, Wall Street selloffs, and DEI funds would break your loyalty to...Colonial Metals | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Royalty Pharma plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Royalty Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RPRX Stock Free RPRX Stock Alerts